TABLE II.
All subjects (n = 264) | Caucasians (n = 162) | African–Americans (n = 102) | |||||||
---|---|---|---|---|---|---|---|---|---|
n | Mean ± SE | p value | n | Mean ± SE | p value | n | Mean ± SE | p value | |
Age at prostatectomy | |||||||||
<60 | 114 | 0.167 ± 0.004 | 0.99 | 66 | 0.169 ± 0.005 | 0.53 | 48 | 0.164 ± 0.007 | 0.47 |
60+ | 150 | 0.167 ± 0.004 | 96 | 0.165 ± 0.004 | 54 | 0.171 ± 0.006 | |||
PSA at diagnosis | |||||||||
Low (<4 ng/mL) | 45 | 0.105 ± 0.004 | 0.88 | 34 | 0.161 ± 0.007 | 0.56 | 11 | 0.153 ± 0.014 | 0.37 |
Moderate (4–10 ng/mL) | 176 | 0.105 ± 0.002 | 98 | 0.170 ± 0.004 | 78 | 0.168 ± 0.005 | |||
High (>10 ng/mL) | 43 | 0.103 ± 0.004 | 30 | 0.162 ± 0.008 | 13 | 0.179 ± 0.013 | |||
Tumor Volume | |||||||||
Low (<20% of gland) | 136 | 0.173 ± 0.004 | 0.02 | 82 | 0.175 ± 0.005 | 0.02 | 54 | 0.171 ± 0.006 | 0.52 |
High (≥20% of gland) | 128 | 0.161 ± 0.004 | 80 | 0.159 ± 0.005 | 48 | 0.165 ± 0.007 | |||
Prostate volume | |||||||||
Low (<65 cc) | 133 | 0.171 ± 0.004 | 0.11 | 78 | 0.172 ± 0.005 | 0.11 | 55 | 0.170 ± 0.006 | 0.59 |
High (≥65 cc) | 131 | 0.163 ± 0.004 | 84 | 0.161 ± 0.005 | 47 | 0.165 ± 0.007 | |||
Tumor stage | |||||||||
2 | 204 | 0.166 ± 0.003 | 0.65 | 125 | 0.167 ± 0.004 | 0.81 | 79 | 0.166 ± 0.005 | 0.31 |
3 or 4 | 60 | 0.169 ± 0.006 | 37 | 0.165 ± 0.007 | 23 | 0.177 ± 0.010 | |||
Advanced Gleason Grade1 | |||||||||
No | 200 | 0.165 ± 0.003 | 0.09 | 122 | 0.167 ± 0.004 | 0.94 | 78 | 0.161 ± 0.005 | 0.005 |
Yes | 64 | 0.175 ± 0.005 | 40 | 0.166 ± 0.007 | 24 | 0.190 ± 0.009 |
No = Gleason sum 6 or less or Gleason sum 7 and primary Gleason grade 3 or lower; Yes 5 Gleason sum 8 or higher or Gleason sum 7 and primary Gleason grade 4 or higher.